Receptos brings in $50mm through tranched Series B round
Receptos Inc. (developing GPCR therapies for autoimmune diseases including MS) has raised $50mm through a tranched Series B round to 11 undisclosed investors.
Drug Discovery Tools
- Drug Discovery Tools
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.